Iovance Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $86,771 | $67,455 | $59,952 | $49,324 |
Gross Profit | 187,298 | 66,047 | 3,288 | -417 |
EBITDA | -67,791 | -84,651 | -101,836 | -106,936 |
EBIT | -71,720 | -93,658 | -113,774 | -118,001 |
Net Income | -71,904 | -91,253 | -111,658 | -116,163 |
Net Change In Cash | 86,771 | 67,455 | 59,952 | 49,324 |
Free Cash Flow | -61,885 | -89,546 | -74,908 | -109,905 |
Cash | 163,078 | 158,134 | 132,469 | 171,668 |
Basic Shares | 406,966 | 364,037 | 334,511 | 322,868 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $263,502 | $164,070 | $1,189 | $238 |
Gross Profit | 256,216 | 40,075 | -9,566 | -21,135 |
EBITDA | -357,110 | -351,672 | -427,432 | -377,743 |
EBIT | -393,049 | -395,278 | -460,559 | -398,878 |
Net Income | -390,978 | -372,177 | -444,037 | -389,923 |
Net Change In Cash | 263,502 | 164,070 | 1,189 | 238 |
Free Cash Flow | -336,244 | -364,046 | -384,110 | -313,182 |
Cash | 163,078 | 115,694 | 114,888 | 231,731 |
Basic Shares | 357,345 | 289,877 | 235,131 | 159,259 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.18 |
2025-09-30 | -$0.25 |
2025-06-30 | -$0.33 |
2025-03-31 | -$0.36 |
